Impact of chronic and acute inflammation on extra- and intracellular iron homeostasis

American Journal of Clinical Nutrition

Volumn 106, Issue , 2017, Pages 1581S-1587S

  Catharine Ross, A ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Acute phase response; C reactive protein; ferroportin; hepatocyte; hepcidin; infancy; intra and extracellular pathogens; macrophage; pregnancy

Indexed keywords

ACUTE PHASE PROTEIN; HAPTOGLOBIN; HEMOPEXIN; HEPCIDIN; IRON; LIVER PROTEIN; TRANSFERRIN;

ACUTE DISEASE; ACUTE PHASE RESPONSE; CHRONIC INFLAMMATION; CONFERENCE PAPER; HUMAN; INFANCY; INFLAMMATION; IRON HOMEOSTASIS; IRON TRANSPORT; LIVER; MICROORGANISM; NONHUMAN; NUTRITIONAL DEFICIENCY; PREGNANCY; PROTEIN SYNTHESIS; REGULATORY MECHANISM; BLOOD; CHRONIC DISEASE; CYTOLOGY; FEMALE; HOMEOSTASIS; HOST PATHOGEN INTERACTION; INFANT; INTESTINE CELL; IRON DEFICIENCY ANEMIA; LIVER CELL; MACROPHAGE; METABOLISM; TROPHOBLAST;

ACUTE DISEASE; ACUTE-PHASE PROTEINS; ACUTE-PHASE REACTION; ANEMIA, IRON-DEFICIENCY; CHRONIC DISEASE; ENTEROCYTES; FEMALE; HEPATOCYTES; HEPCIDINS; HOMEOSTASIS; HOST-PATHOGEN INTERACTIONS; HUMANS; INFANT; IRON; LIVER; MACROPHAGES; PREGNANCY; TROPHOBLASTS;

EID: 85037641137     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.117.155838     Document Type: Conference Paper

References (52)

1. Thurnham DI. Interactions between nutrition and immune function: using inflammation biomarkers to interpret micronutrient status. Proc Nutr Soc 2014;73:1-8.
2. Raiten DJ, Sakr Ashour FA, Ross AC, Meydani SN, Dawson HD, Stephensen CB, Brabin BJ, Suchdev PS, van Ommen B. Inflammation and Nutritional Science for Programs/Policies and Interpretation of Research Evidence (INSPIRE). J Nutr 2015;145(Suppl):1039S-108S.
3. Anderson GJ, Wang F. Essential but toxic: controlling the flux of iron in the body. Clin Exp Pharmacol Physiol 2012;39:719-24.
4. Soares MP, Wiess G. The Iron age of host-microbe interactions. EMBO Rep 2015;16:1482-500.
5. Drakesmith H, Prentice AM. Hepcidin and the iron-infection axis. Science 2012;338:768-72.
6. Gasche C, Lomer MCE, Cavill I, Weiss G. Iron, anaemia, and inflammatory bowel diseases. Gut 2004;53:1190-7.
7. Ganz T. Cellular iron: ferroportin is the only way out. Cell Metab 2005; 1:155-7.
8. Donovan A, Lima CA, Pinkus JL, Pinkus GS, Zon LI, Robine S, Andrews NC. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab 2005;1:191-200.
9. Davies LC, Jenkins SJ, Allen JE, Taylor PR. Tissue-resident macrophages. Nat Immunol 2013;14:986-95.
10. Bode JG, Albrecht U, Håussinger D, Heinrich PC, Schaper F. Hepatic acute phase proteins-regulation by IL-6-And IL-1-type cytokines involving STAT3 and its crosstalk with NF-kB-dependent signaling. Eur J Cell Biol 2012;91:496-505.
11. Pietrangelo A, Trautwein C. Mechanisms of disease: the role of hepcidin in iron homeostasis-implications for hemochromatosis and other disorders. Nat Clin Pract Gastroenterol Hepatol 2004;1:39-45.
12. Agarwal N, Prchal JT. Anemia of chronic disease (anemia of inflammation). Acta Haematol 2009;122:103-8.
13. Nemeth E, Ganz T. Anemia of inflammation. Hematol Oncol Clin North Am 2014;28:671-81.
14. Koenig MD, Tussing-Humphreys L, Day J, Cadwell B, Nemeth E. Hepcidin and iron homeostasis during pregnancy. Nutrients 2014;6: 3062-83.
15. Gozzelino R. The pathophysiology of heme in the brain. Curr Alzheimer Res 2016;13:174-84.
16. Winterbourn CC. Toxicity of iron and hydrogen peroxide: the Fenton reaction. Toxicol Lett 1995;82-83:969-74.
17. Wagener FA, Volk HD, Willis D, Abraham NG, Soares MP, Adema GJ, Figdor CG. Different faces of the heme-heme oxygenase system in inflammation. Pharmacol Rev 2003;55:551-71.
18. Smith A, McCulloh RJ. Hemopexin and haptoglobin: allies against heme toxicity from hemoglobin not contenders. Front Physiol 2015;6: 187.
19. Gabay C, Kushner I. Acute phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-54.
20. Greenberg AS, Obin MS. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 2006;83(Suppl):461S-5S.
21. Huh JY, Park YJ, Ham M, Kim JB. Crosstalk between adipocytes and immune cells in adipose tissue inflammation and metabolic dysregulation in obesity. Mol Cells 2014;37:365-71.
22. Aldred AR, Schreiber G. The negative acute phase proteins. In: Mackiewicz A, Kushner I, Bauman H, editors. Acute phase proteins molecular biology, biochemistry, and clinical applications. Boca Raton (FL): CRC Press; 1993. p. 21-37.
23. Gitlin JD, Colten HR. Molecular biology of the acute phase proteins. In: Pick E, Landy M, editors. Lymphokines. San Diego (CA): Academic Press; 1987. p. 123-53.
24. Kilicarslan A, Uysal A, Roach EC. Acute phase reactants. Acta Medica (Cordoba) 2013;2:2-7.
25. Schreiber G, Tsykin A, Aldred AR, Thomas T, FungW-P, Dickson PW, Cole T, Birch H, De Jong FA, Milland J. The acute phase response in the rodent. Ann N Y Acad Sci 1989;557:61-85.
26. van Wijk F, Cheroutre H. Mucosal T cells in gut homeostasis and inflammation. Expert Rev Clin Immunol 2010;6:559-66.
27. Sampson HA. Food allergies. In: Feldman M, Friedman LS, Brandt LJ, editors. Sleisenger and Fordtran's gastrointestinal and liver disease. Philadelphia: Elsevier, Saunders; 2015.
28. Harrison OJ, Powrie FM. Regulatory T cells and immune tolerance in the intestine. Cold Spring Harb Perspect Biol 2013;5:a018341.
29. Rozing J, de Geus B. Changes in the intestinal lymphoid compartment throughout life: implications for the local generation of intestinal T cells. Int Rev Immunol 1995;12:13-25.
30. Burroughs AK. The hepatic artery, portal venous system and portal hypertension: the hepatic veins and liver in circulatory failure. In: Dooley JS, Lok ASF, Burroughs AK, Heathcote EJ, editors. Sherlock's diseases of the liver and biliary system. London: Wiley Blackwell; 2011. p. 152-209.
31. Trautwein C, Böker K, Manns MP. Hepatocyte and immune system: acute phase reaction as a contribution to early defence mechanisms. Gut 1994;35:1163-6.
32. Ishihara K, Hirano T. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev 2002;13:357-68.
33. Hirano T, Ishihara K, Hibi M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 2000;19:2548-56.
34. Piperno A, Mariani R, Trombini P, Girelli D. Hepcidin modulation in human diseases: from research to clinic. World J Gastroenterol 2009; 15:538-51.
35. Maisetta G, Petruzzelli R, Brancatisano FL, Esin S, Vitali R, Campa M, Batoni G. Antimicrobial activity of human hepcidin 20 and 25 against clinically relevant bacterial strains: effect of copper and acidic pH. Peptides 2010;31:1995-2002.
36. Krause A, Neitz S, Magert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, Adermann K. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 2000;480:147-50.
37. Shi W, Wang H, Zheng X, Jiang X, Xu Z, Shen H, Li M. HNF-4alpha negatively regulates hepcidin expression through BMPR1A in HepG2 cells. Biol Trace Elem Res 2017;176:294-304.
38. Harrison-Findik DD, Lu S. The effect of alcohol and hydrogen peroxide on liver hepcidin gene expression in mice lacking antioxidant enzymes, glutathione peroxidase-1 or catalase. Biomolecules 2015;5: 793-807.
39. Bayele HK, Balesaria S, Srai SK. Phytoestrogens modulate hepcidin expression by Nrf2: implications for dietary control of iron absorption. Free Radic Biol Med 2015;89:1192-202.
40. Bayele HK, Srai SKS. Genetic variation in hepcidin expression and its implications for phenotypic differences in iron metabolism. Haematologica 2009;94:1185-8.
41. Legrand D. Lactoferrin, a key molecule in immune and inflammatory processes. Biochem Cell Biol 2012;90:252-68.
42. Papanastasiou DA, Vayenas DV, Vassilopoulos A, Repanti M. Concentration of iron and distribution of iron and transferrin after experimental iron overload in rat tissues in vivo: study of the liver, the spleen, the central nervous system and other organs. Pathol Res Pract 2000; 196:47-54.
43. Gozzelino R, Jeney V, Soares MP. Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol 2010;50:323-54.
44. Origassa CS, Cǎmara NO. Cytoprotective role of heme oxygenase-1 and heme degradation derived end products in liver injury. World J Hepatol 2013;5:541-9.
45. Haram K, Augensen K, Elsayed S. Serum protein pattern in normal pregnancy with reference to acute-phase reactants. Br J Obstet Gynaecol 1983;90:139-45.
46. Mor G, Cardenas I, Abrahams V, Guller S. Inflammation and pregnancy: the role of the immune system at the implantation site. Ann N Y Acad Sci 2011;1221:80-7.
47. Romero R, Espinoza J, Gonçalves LF, Kusanovic JP, Friel LA, Nien JK. Inflammation in preterm and term labour and delivery. Semin Fetal Neonatal Med 2006;11:317-26.
48. Hedengran KK, Nelson D, Andersen MR, Stender S, Szecsi PB. Hepcidin levels are low during pregnancy and increase around delivery in women without iron deficiency-A prospective cohort study. J Matern Fetal Neonatal Med 2016;29:1506-8.
49. Levytska K, Kingdom J, Baczyk D, Drewlo S. Heme oxygenase-1 in placental development and pathology. Placenta 2013;34:291-8.
50. Marchini G, Berggren V, Djilali-Merzoug R, Hansson LO. The birth process initiates an acute phase reaction in the fetus-newborn infant. Acta Paediatr 2000;89:1082-6.
51. Hooper SB, Te Pas AB, Kitchen MJ. Respiratory transition in the newborn: a three-phase process. Arch Dis Child Fetal Neonatal Ed 2016;101:F266-71.
52. Wieringa FT, Dijkhuizen MA, Clive E, West CE, Northrop-Clewes CA, Muhilal. Estimation of the effect of the acute phase response on indicators of micronutrient status in Indonesian infants. J Nutr 2002;132: 3061-6.